Skip to main content

Periodontal Therapeutic Market is Systematically at a Flattering CAGR of 9.2% During Forecast to 2023


Market Overview:
Periodontal continues to be one of the major causes of tooth loss and a major oral health issue. The disease is common in both developed and developing countries, affecting nearly 20 to 50% of the global population. Over the years, different periodontal therapies have come up with a high degree of effectivity. Both surgical and non-surgical treatment options available.
Global Periodontal Therapeutic Market Trends set to witness a strong growth in the forthcoming years. The latest study conducted by Market Research Future (MRFR) reveals that the global periodontal therapeutic market will surge at 9.2% CAGR during 2018 to 2023. 
The onset of periodontal issues could be triggered by poor oral hygiene, diabetes mellitus, stress, smoking and hormonal changes in females. The incidence rate has continued to grow, which is also driving the demand for periodontal therapeutic. As per World Health Organization (WHO), there is a high incident rate of gingival bleeding in adults worldwide.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6562

Meanwhile, 10 to 15% of adults are affected with deep periodontal pockets (6 mm or more) globally. Major drivers of the global periodontal therapeutic market include rising geriatric population and growing worldwide healthcare spending. Nevertheless, poor level of awareness and negligence towards oral hygiene, especially in third-world countries are among the key bottlenecks for the market.
Competitive Landscape 
·         Tolmar Inc
·         Align Technology Inc
·         3M-ESPE
·         Nobel Biocare Holdings AG
·         Orapharm
·         Valeant Pharmaceuticals Int
·         Mallinckrodt Pharmaceuticals
·         Teva Pharmaceutical Industries Limited
·         Ultradent Products Inc
·         Eli Lilly & Company
·         Glidewell Laboratories
·         Den-Mat Holdings

Segmental Overview
·         The segmental analysis on the global periodontal therapeutic market is based on treatment, type and end-users.
·         By treatment, the market has bees segmented into local antibiotics and systematic antibiotics.
·         Based on type, the market has been segmented into aggressive periodontitis, chronic periodontitis, gingivitis and necrotizing periodontal disease.
·         By end-user, the market has been segmented into hospitals and dental clinics

Global Periodontal Therapeutic Market: Regional Segmentation
A booming need for more oral hygiene appeal in the field of periodontal treatment is being observed worldwide. The rising awareness regarding oral hygiene and increasing incidence of the periodontal disorder among people are factors responsible for the growth of the market in this region.
The market in the Americas is expected to boost the global periodontal therapeutic market owing to technological advancement and increasing incidences of the periodontal disorder among diabetic patients. According to recent findings from the Centers for Disease Control and Prevention (CDC), half of Americans aged 30 or older have periodontitis, the more advanced form of periodontal disease. This equals approximately 64.7 million Americans. This is largely attributed to the accessibility of an urban healthcare infrastructure. The European market is expected to be the second-largest due to government funding and support from the healthcare sector coupled with the rising prevalence of the periodontal disorder. However, Asia-Pacific is projected to dominate in terms of growth rate over the forecast period owing to rising investment towards R&D activities and unhealthy lifestyle which are resulting in an increased prevalence of obesity. Rising geriatric population and the increasing prevalence of diabetes in this region have a positive influence on the development of the periodontal therapeutic market in this region.  The Middle East and Africa account for the smallest share due to lack of medical technology and poor medical facilities. Emerging economies such as India and China are leading to growth in demand for periodontal therapeutic owing to increasing number of healthcare awareness programs, government investment in healthcare and favorable healthcare insurance coverage. National Oral Health Programmed (NOHP) was conceptualized by the Indian Dental Association to ensure optimal oral health for all by increasing awareness, assuring excellent service and high-quality dental care



Labels:

Comments

Post a Comment

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...
Post a Comment
Read more

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...
Post a Comment
Read more

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...
Post a Comment
Read more